DNTH Heads Into Earnings With a Divided Short Book and Bullish Street Consensus
Dianthus Therapeutics reports today after market close with short sellers in retreat and analysts broadly constructive — but insider selling from the CFO adds a note of caution to an otherwise positive setup. The most…